Tommy G. Thompson, Director at UNITED THERAPEUTICS Corp (UTHR), sold 4,000 shares at $537.62 ($2.2M) on 2026-03-26, disclosed to the SEC on 2026-03-26.
Seasonal sale ($2.2M) by Director — this insider has traded UTHR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $537.62 | 275 | $148K | 6.9% |
| 2 | $537.62 | 275 | $148K | 6.9% |
| 3 | $539.25 | 1,414 | $762K | 35.4% |
| 4 | $539.25 | 1,414 | $762K | 35.4% |
| 5 | $540.17 | 311 | $168K | 7.8% |
| 6 | $540.18 | 311 |
| $168K |
| 7.8% |
| Total | $539.17 avg | 4,000 | $2.2M | 100% |
| Filing → |
| UTHR | SELL | 2025-12-19 | $911K | — | Filing → |
| UTHR | SELL | 2025-09-10 | $3.7M | — | Filing → |
| DOC | BUY | 2025-05-28 | $200K | — | Filing → |